IL6 and hepatocellular carcinoma: The percentage of non-tumoral HSCs that co-expressed IL-6 and α-SMA was very low, and showed no significant difference between the two HCC groups (5.4 ± 5.90% vs. 4.0 ± 5.34%, P = 0.299) (Fig 3F).